Stock Analiz

Orasure Technologies Inc. OSUR

Medical/Dental Instruments · data as of November 13, 2026

$3.62Market cap $250M
Open the interactive analysis →

Orasure Technologies Inc. (OSUR) is a healthcare company listed in the US with a market value of about $250M. In the twelve months to September 30, 2026 it had revenue of $116M and net income of -$49M, a net margin of -41.7%.

Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of -8% a year, a 5-year average ROIC of -4%.

About Orasure Technologies

Orasure Technologies is listed in the US and classified in medical/dental instruments. Revenue went from $106M in 2014 to $115M in 2025, growth of about 0.7% a year. It was profitable in 5 of the last 10 years in our data. It spends 37% of revenue on research and development.

Score: 0.6 / 5

Value0/5
Future growth1/5
Track record0/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S2.2
P/B0.8
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-19.9%
Shareholder yield6.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)-38.1%
Revenue growth (5 yrs, per year)-7.7%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-14.3%
ROIC (5-yr avg.)-4.2%
Profitable years (of last 10)5
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$116M$115M$186M$405M$387M$234M$172M$155M$182M$167M$128M
Net income-$49M-$69M-$20M$54M-$17M-$23M-$15M$17M$20M$31M$20M
Free cash flow-$50M-$53M$24M$136M-$54M-$57M-$21M$490000$33M$24M$20M
EPS (diluted)$-0.69$-0.94$-0.26$0.72$-0.24$-0.32$0.22$0.27$0.33$0.51$0.35
Net margin-41.7%-59.8%-10.5%13.2%-4.4%-9.8%-8.7%10.8%11.2%18.5%15.4%
ROIC—-16.1%-5.2%7.0%-4.7%-2.1%-1.0%4.7%6.5%11.8%10.6%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 2 analysts is $5.50, 52% above the current price; targets range from $4.00 to $7.00; the consensus rating is “Buy”; expected EPS is $-0.74 for the fiscal year ending December 31, 2026.

Frequently asked questions

Does Orasure Technologies pay a dividend?

Not currently.

Is Orasure Technologies a good stock to buy?

We do not give buy or sell advice. Orasure Technologies scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.